TrialClinical pharmacology and therapeutics2021

Population Pharmacokinetics and Pharmacodynamics of the Neutralizing Antibodies Bamlanivimab and Etesevimab in Patients With Mild to Moderate COVID-19 Infection.

Emmanuel Chigutsa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.